When discussing the value of screening for 22q, the authors concluded that, “the PPV of cfDNA for 22q11.2DS is higher and the false positive rate is lower than that associated with other accepted ...

Non-invasive prenatal testing (NIPT) on pregnant women to detect the risk of a fetus having rare genetic abnormalities may often be wrong, according to recent reports. These tests, according to ...

WASHINGTON , Jan. 6, 2026 /PRNewswire/ -- A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect pregnant mothers at ...

Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...

During a pregnancy, women are offered prenatal genetic screening and diagnostic testing to determine whether a fetus is healthy or has certain genetic disorders or anomalies. This information can help ...

Nearly 100 Republican legislators are demanding answers from the Food and Drug Administration (FDA) on the nature and validity of non-invasive prenatal testing (NIPT). Rep. Chip Roy, R-Texas, Sen.

A novel study has analyzed the cost-effectiveness of different Down syndrome (DS) screening strategies. The result confirms that noninvasive prenatal testing (NIPT) outperforms second-trimester serum ...

Hyderabad, Jan. 09, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the non-invasive prenatal testing market is valued at USD 3.90 billion in 2025 and estimated to grow from USD 4.42 ...

The tests look for genetic abnormalities in a fetus, according to the FDA. Common prenatal tests done to test for genetic abnormalities are the subject of a new warning from the U.S. Food and Drug ...

A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect the risk in pregnant mothers of transmitting cytomegalovirus (CMV ...